- Report
- October 2024
- 199 Pages
Global
From €3399EUR$3,545USD£2,840GBP
€3776EUR$3,939USD£3,155GBP
- Report
- December 2024
- 175 Pages
Global
From €4793EUR$5,000USD£4,005GBP
- Report
- October 2022
- 226 Pages
Global
From €3422EUR$3,570USD£2,860GBP
The injectable cement market pertains to a specialized segment within the broader medical infusions and injectables sector, primarily focused on orthopedic and dental applications. These cements are typically used for the fixation of prosthetic devices in various orthopedic surgeries, including joint arthroplasty and spinal surgeries, as they provide immediate structural support and stability to the implanted devices. Injectable bone cements are also utilized in vertebroplasty and kyphoplasty procedures to treat vertebral compression fractures. The composition of these cements generally includes a polymer-based powder and a liquid monomer which, when mixed, polymerize to form a hardened substance. In addition to their structural function, some injectable cements may be impregnated with antibiotics to reduce the risk of post-surgical infections.
Key players in the injectable cement market include Stryker Corporation, Zimmer Biomet, DePuy Synthes (a Johnson & Johnson company), and Heraeus Medical. Other notable companies include Teknimed, a firm that specializes in synthetic bone cements, and DJO Global (Colfax Corporation), which provides a variety of orthopedic products including bone cement solutions. These companies continuously innovate and invest in research and development to improve the clinical outcomes of their products and to expand their portfolios to meet diverse medical requirements. Show Less Read more